Development of a novel quantitative lateral flow assay for vancomycin for therapeutic drug monitoring
Abstract Antibiotic optimisation through therapeutic drug monitoring (TDM) is a key strategy in tackling antimicrobial resistance. However, current quantification methods rely on laboratory-based equipment, delaying timely dose adjustments. We developed a novel point-of-care lateral flow assay (LFA)...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-09145-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|